Package leaflet: Information for the user NuvaRing® 0.120 mg/0.015 mg per 24 hours, Vaginal delivery system etonogestrel/ethiny
![These highlights do not include all the information needed to use NuvaRing safely and effectively. See full prescribing information for NuvaRing. NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring)Initial U.S. Approval: 2001 These highlights do not include all the information needed to use NuvaRing safely and effectively. See full prescribing information for NuvaRing. NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring)Initial U.S. Approval: 2001](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=nuvaring-21.jpg&id=559000)
These highlights do not include all the information needed to use NuvaRing safely and effectively. See full prescribing information for NuvaRing. NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring)Initial U.S. Approval: 2001
![Qualitative exploration of intrinsic and extrinsic factors that influence acceptability of semisoft vaginal suppositories | BMC Women's Health | Full Text Qualitative exploration of intrinsic and extrinsic factors that influence acceptability of semisoft vaginal suppositories | BMC Women's Health | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12905-018-0657-2/MediaObjects/12905_2018_657_Fig3_HTML.png)
Qualitative exploration of intrinsic and extrinsic factors that influence acceptability of semisoft vaginal suppositories | BMC Women's Health | Full Text
![These highlights do not include all the information needed to use NuvaRing safely and effectively. See full prescribing information for NuvaRing. NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring)Initial U.S. Approval: 2001 These highlights do not include all the information needed to use NuvaRing safely and effectively. See full prescribing information for NuvaRing. NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring)Initial U.S. Approval: 2001](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=nuvaring-14.jpg&id=559000)